Clinical Trials Logo

Clinical Trial Summary

The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.


Clinical Trial Description

The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05205551
Study type Observational [Patient Registry]
Source Natera, Inc.
Contact ProTECT Team
Phone (650) 249-9090
Email [email protected]
Status Recruiting
Phase
Start date October 1, 2021
Completion date December 2027

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05064462 - TTV Viral Load in Heart Transplant Recipients
Recruiting NCT04973943 - Donor-derived Cell Free DNA as a New Biomarker in Cardiac Acute Rejection
Completed NCT03477383 - A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
Recruiting NCT04707872 - Trifecta-Heart cfDNA-MMDx Study
Recruiting NCT04921774 - Research on Patients With Heart Transplantation
Recruiting NCT04226521 - Extracorporeal Photopheresis and Early Cardiac Graft Vasculopathy N/A
Completed NCT03393793 - HEart trAnsplantation Registry of piTie-Salpetriere University Hospital
Completed NCT01136135 - Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection N/A
Active, not recruiting NCT03833050 - The TOGETHER Project - Heart
Active, not recruiting NCT03373227 - Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen Phase 2
Active, not recruiting NCT03695601 - Surveillance HeartCare® Outcomes Registry
Active, not recruiting NCT01397812 - Heartsbreath Test for Heart Transplant Rejection N/A
Active, not recruiting NCT05184426 - MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)